Chronotherapeutics: A new vista in novel drug delivery systems

International Journal of Pharmaceutical Sciences Review and Research

Volumn 6, Issue 2, 2011, Pages 66-75

  Prasanthi, N I ^a   Swathi, G ^a   Manikiran, S S ^a  

^a CHALAPATHI INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Asthma; Chronopharmacokinetics; Chronotherapeutics; Circadian rhythms; Intelligent drug delivery systems

Indexed keywords

AMINOGLYCOSIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CISPLATIN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INSULIN; KETOPROFEN; LIDOCAINE; LOCAL ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT; PRILOCAINE; PROPRANOLOL; SALAZOSULFAPYRIDINE; SALICYLIC ACID; SUMATRIPTAN; THEOPHYLLINE; VERAPAMIL;

ARTHRITIS; ARTICLE; ASTHMA; BEDTIME DOSAGE; CANCER THERAPY; CARDIOVASCULAR DISEASE; CHRONOPHARMACOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG MEGADOSE; DRUG METABOLISM; DUODENUM ULCER; ESSENTIAL HYPERTENSION; EVENING DOSAGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFUSION PUMP; ISCHEMIC HEART DISEASE; MIGRAINE; MORNING DOSAGE; NEPHROTOXICITY; NOCTURNAL ASTHMA; OSTEOARTHRITIS; PAIN; PEPTIC ULCER; RHEUMATOID ARTHRITIS; TARGET CELL;

EID: 79952058518     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Reinberg A, Halberg F, Circadian chronopharmacology, Annu. Rev. Pharmacol., 11, 1971, 455-492.
2. Smolensky MH, Labrecque G, Chronotherapeutics, Pharm News, 4, 1997, 10-16.
3. Maronde E, Stehle EH, The mammalian pineal gland: known facts, unknown facets, Trends Endocrinol. Metab., 18, 2007, 142-149.
4. Vener KJ, Reddy A, Timed treatment of the arthritic diseases: a review and hypothesis, Arthritis Rheum, 22, 1992, 83-97.
5. Auvil-Novak SE, The chronobiology, chronopharmacology, and chronotherapeutics of pain, Annu. Rev. Nurs. Res., 17, 1999, 133-153.
6. Anwar YA, White WB, Chronotherapeutics for cardiovascular disease, Drugs, 55, 1998, 631-643.
7. Muller JE, Tofler GH, Stone PH, Circadian variation and triggers of onset of acute cardiovascular disease, Circulation, 79, 1989, 733-743.
8. Moore JG, Englert E, Circadian rhythm of gastric acid secretion in man, Nature, 226, 1970, 1261-1262.
9. Levi F, Circadian chronotherapy for human cancers, Lancet Oncol, 2, 2001, 307-315.
10. Hori K, Zhang QH, Li HC, Saito S, Sato Y, Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow, Int. J. Cancer, 65, 1996, 360-364.
11. Simvastatin: a one-a-day treatment for hypercholesterolemia, Pebble Beach, California, Am. J. Med, 87, 1989, 1-59.
12. Malherbe C, De Gasparo M, De Hertogh R, Hoet JJ, Circadian variations of blood sugar and plasma insulin levels in man, Diabetologia, 5, 1969, 397-404.
13. Shiga T, Fujimura A, Tateishi T, The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects, Eur J Clin Pharmacol, 44, 1993, 489-92.
14. Bernard Bruguerolle, Chronopharmacokinetics Current Status, Clin Pharmacokinet, 35, 1998, 83-94.
15. Reinberg A, Pauchet F, Ruff F, Gervais A, Smolensky MH, Levi F, Gervais P, Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma, Chronobiol. Int, 4, 1987, 409-419.
16. Lemmer B, Circadian rhythms and drug delivery, J J Contr Release. Controlled Release, 16, 1991, 63-74.
17. Shiga, Fujimura A, Tateishi T, Ohashi K, Ebihara A, Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive patients, J Clin Pharmacol, 33, 1993, 756-761.
18. Bernard Bruguerolle, Gaston Labrecque, Rhythmic pattern in pain and their chronotherapy, Adv. Drug Del Rev, 59, 2007, 883-895
19. Youan BC, Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery, J. Control. Rel, 98, 2004, 337-353.
20. FDA, Electronic Orange Book, Administration, Washington, DC, 2003 F.a. D.
21. Leslie S, Euroceltique, SA, United States, 1982, 20.
22. Hoffman W, Smith R, Willard A, Merck & Co., United States, 1984, p. 26.
23. Jao F, Wong P, Huynh H, McChesney K, Alza Corporation, United States, 1992, p. 17.
24. White WB, Mehrotra DV, Black HR, Fakouhi TD, Effects of controlled-onset extended-release verapamil on nocturnal blood pressure, Am. J. Cardiol, 80, 1997, 469-474.
25. Panoz D, Geoghegan E, Elan Corporation, United States, 1989, p. 49.
26. Smith DH, Neutel JM, Weber MA, A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning, Am. J. Hypertens, 14, 2001, 14-19.
27. Fuisz R, Fuisz Technologies Ltd, United States, 1996, p. 34.
28. Percel P, Vishnupad K, Venkatesh G, Eurand Pharmaceuticals Ltd., United States, 2002, p.13.
29. Sershen S, West J, Implantable, polymeric systems for modulated drug delivery, Adv. Drug Deliv. Rev, 54, 2002, 1225-1235.
30. Baichwal A, Staniforth J, Penwest Pharmaceuticals Co., United States, 2002, p. 19.
31. Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Cima. Oral dosage forms fabricated by three dimensional printing, J.Control.Release, 66, 2000, 1-9.
32. Santini ST, Cima MJ, Langer R, A controlled-release microchip, Nature, 397, 1999, 335-338.
33. Hradetzky D, Transdermal drug delivery devices for chronotherapy, Med. Device Technol, 19, 2008, 45-47.
34. Youan BBC, Chronopharmaceutics: Science and Technology for Biological Rhythm Guided Therapy and Prevention of Diseases, John Wiley & Sons, Hoboken, NJ, USA, 2009.